The phrase "a significant decrease in risk of" is correct and usable in written English.
It can be used in contexts discussing health, safety, finance, or any situation where risk is being evaluated and compared.
Example: "The new treatment has shown a significant decrease in risk of complications for patients."
Alternatives: "a notable reduction in risk of" or "a considerable drop in risk of".
Recent antimalarial treatments were associated with a significant decrease in risk of P. vivax by both LDR and LM but an increase in risk of LDR but not LM positive P. falciparum, while reported febrile illness in the previous 2 weeks was associated with a significant decrease in risk of LDR positive P. vivax and LDR and LM positive P. malariae infections.
Uncomplicated falciparum disease, on the other hand, remains common throughout most of childhood and a significant decrease in risk of infection is only seen in adolescence and early adulthood [1], [3], [4], [5].
30, 31 In patients with a 10-year fracture risk >6.9%, bazedoxifene was associated with a significant decrease in risk of morphometric vertebral fractures.
Moreover, in patients with 10-year fracture probabilities at or above 16%, bazedoxifene was associated with a significant decrease in risk of all clinical fractures.
A case control study of the 1980 heat wave in St .Louis and Kansas City, Missouri, found a significant decrease in risk of nonfatal heat-stroke associated with an incremental increase in greenery surrounding residences (Kilbourne et al. 1982).
Systemic therapy was associated with a significant decrease in risk of all CVEs in Pso/PsA (RR, 0.75; 95% CI 0.63 to 0.91; p=0.003) (see online supplementary figure S3).
Studies have demonstrated a significant decrease in risk with with two or more hours of standing/walking per day.
Early detection that leads to prevention of vision loss, alone, will lead to significant decrease in risk of early vision loss.
However, in contrast with TNF inhibitors, methotrexate was not associated with a significant decrease in the risk of strokes and major adverse cardiac events, although trends towards decreasing risk of heart failure were found (figure 2B).
The present study was designed to find out whether prophylactic administration of surfactant leads to a significant decrease in the risk of neonatal mortality and neonatal morbidity.
The Prevent Recurrence Of Osteoporotic Fractures (PROOF) study has shown a significant decrease in the risk of vertebral fracture in patients treated with calcitonin 200IU.
